Operaciones Bruker - BRKR CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Condiciones de trading
| Diferencial | 0.14 | ||||||||
|
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.025457% | ||||||||
|
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | 0.003235% | ||||||||
| Horario tarifa nocturna | 21:00 (UTC) | ||||||||
| Cantidad comercializada mínima | 1 | ||||||||
| Divisa | USD | ||||||||
| Margen | 20% | ||||||||
| Mercado de valores | United States of America | ||||||||
| Comisión por operación | 0% |
*Information provided by Capital.com
Bruker Corp ESG Risk Ratings
High Medium Low Negligible
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Estadísticas clave
| Cierre previo* | 62.52 |
| Abrir* | 61.98 |
| Cambio de 1 año* | -1.59% |
| Rango del día* | 61.8 - 62.86 |
| Rango de 52 semanas | 48.42-84.84 |
| Volumen medio (10 días) | 826.23K |
| Volumen medio (3 meses) | 18.18M |
| Capitalización de mercado | 10.84B |
| Ratio P/E | 35.17 |
| Acciones en circulación | 146.73M |
| Ingresos | 2.62B |
| EPS | 2.10 |
| Dividendo (Rendimiento %) | 0.27075 |
| Beta | 1.16 |
| Próxima fecha de resultados | Aug 1, 2023 |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Cierre | Change | Change (%) | Apertura | High | Low |
|---|---|---|---|---|---|---|
| Jun 29, 2022 | 62.88 | 0.68 | 1.09% | 62.20 | 63.00 | 61.54 |
| Jun 28, 2022 | 62.52 | -1.52 | -2.37% | 64.04 | 64.97 | 62.31 |
| Jun 27, 2022 | 63.77 | -0.38 | -0.59% | 64.15 | 64.49 | 63.03 |
| Jun 24, 2022 | 64.11 | -1.45 | -2.21% | 65.56 | 65.61 | 63.90 |
| Jun 23, 2022 | 64.81 | 3.46 | 5.64% | 61.35 | 65.02 | 61.35 |
| Jun 22, 2022 | 61.10 | 1.18 | 1.97% | 59.92 | 61.86 | 59.79 |
| Jun 21, 2022 | 60.59 | 0.35 | 0.58% | 60.24 | 61.37 | 59.80 |
| Jun 17, 2022 | 59.19 | -0.19 | -0.32% | 59.38 | 61.24 | 59.17 |
| Jun 16, 2022 | 59.33 | 1.11 | 1.91% | 58.22 | 60.02 | 58.22 |
| Jun 15, 2022 | 61.16 | 0.91 | 1.51% | 60.25 | 61.95 | 60.02 |
| Jun 14, 2022 | 60.12 | 0.51 | 0.86% | 59.61 | 60.49 | 58.34 |
| Jun 13, 2022 | 59.71 | -0.06 | -0.10% | 59.77 | 60.15 | 58.90 |
| Jun 10, 2022 | 61.64 | -0.44 | -0.71% | 62.08 | 62.62 | 61.22 |
| Jun 9, 2022 | 63.52 | 1.76 | 2.85% | 61.76 | 64.42 | 61.76 |
| Jun 8, 2022 | 64.27 | 1.73 | 2.77% | 62.54 | 64.69 | 62.54 |
| Jun 7, 2022 | 63.91 | 1.33 | 2.13% | 62.58 | 64.22 | 62.28 |
| Jun 6, 2022 | 63.14 | -0.15 | -0.24% | 63.29 | 63.98 | 62.63 |
| Jun 3, 2022 | 63.22 | 1.22 | 1.97% | 62.00 | 64.14 | 62.00 |
| Jun 2, 2022 | 64.59 | 3.30 | 5.38% | 61.29 | 64.72 | 60.95 |
| Jun 1, 2022 | 61.26 | -1.12 | -1.80% | 62.38 | 63.54 | 60.48 |
Bruker Events
| Hora (UTC) (UTC) | País | Evento |
|---|---|---|
| Friday, June 9, 2023 | ||
| Hora (UTC) (UTC) 13:00 | País US
| Evento Bruker Corp at Jefferies Healthcare Conference Bruker Corp at Jefferies Healthcare ConferenceForecast -Previous - |
| Thursday, June 15, 2023 | ||
| Hora (UTC) (UTC) 15:00 | País US
| Evento Bruker Corp To Host Investor Day Bruker Corp To Host Investor DayForecast -Previous - |
| Tuesday, August 1, 2023 | ||
| Hora (UTC) (UTC) 10:59 | País US
| Evento Q2 2023 Bruker Corp Earnings Release Q2 2023 Bruker Corp Earnings ReleaseForecast -Previous - |
| Wednesday, November 1, 2023 | ||
| Hora (UTC) (UTC) 12:30 | País US
| Evento Q3 2023 Bruker Corp Earnings Release Q3 2023 Bruker Corp Earnings ReleaseForecast -Previous - |
- Anual
- Trimestral
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Ingresos totales | 2530.7 | 2417.9 | 1987.5 | 2072.6 | 1895.6 |
| Ingresos | 2530.7 | 2417.9 | 1987.5 | 2072.6 | 1895.6 |
| Coste de los ingresos, total | 1224.1 | 1208.3 | 1047.7 | 1077.3 | 995.6 |
| Beneficio bruto | 1306.6 | 1209.6 | 939.8 | 995.3 | 900 |
| Gastos totales de explotación | 2098 | 2004.6 | 1739.2 | 1771.7 | 1633.2 |
| Gastos de venta/general/administración Gastos, total | 609.8 | 562.3 | 474.5 | 502.3 | 449.2 |
| Investigación y desarrollo | 235.9 | 220.8 | 198 | 187.7 | 173.4 |
| Gastos (ingresos) extraordinarios | 27.4 | 13.2 | 19 | 4.4 | 15 |
| Ingresos de explotación | 432.7 | 413.3 | 248.3 | 300.9 | 262.4 |
| Ingresos por intereses (gastos), netos No operativos | -17.8 | -17.5 | -19.2 | -18 | -14.4 |
| Otros, netos | -1 | -2.2 | -3.3 | -2.5 | -3.3 |
| Ingresos netos antes de impuestos | 413.9 | 393.6 | 225.8 | 280.4 | 244.7 |
| Ingresos netos después de impuestos | 297.5 | 280.6 | 161.4 | 198 | 181 |
| Intereses menores | -1.9 | -3.5 | -3.6 | -0.8 | -1.3 |
| Beneficio neto antes de partidas extra. Elementos | 296.6 | 277.1 | 157.8 | 197.2 | 179.7 |
| Ingresos netos | 296.6 | 277.1 | 157.8 | 197.2 | 179.7 |
| Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | 296.6 | 277.1 | 157.8 | 197.2 | 179.7 |
| Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | 296.6 | 277.1 | 157.8 | 197.2 | 179.7 |
| Beneficio neto diluido | 296.6 | 277.1 | 157.8 | 197.2 | 179.7 |
| Promedio ponderado de acciones diluidas | 149.4 | 152.9 | 154.6 | 156.6 | 157.2 |
| BPA diluido sin partidas extraordinarias | 1.98527 | 1.8123 | 1.0207 | 1.25926 | 1.14313 |
| Dividends per Share - Common Stock Primary Issue | 0.2 | 0.16 | 0.16 | 0.16 | 0.16 |
| BPA normalizado diluido | 2.1171 | 1.88969 | 1.12981 | 1.303 | 1.21371 |
| Total de partidas extraordinarias | |||||
| Other Operating Expenses, Total | 0.8 | ||||
| Equity In Affiliates | 1 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Ingresos totales | 685.3 | 708.4 | 638.9 | 588.4 | 595 |
| Ingresos | 685.3 | 708.4 | 638.9 | 588.4 | 595 |
| Coste de los ingresos, total | 325.4 | 342.8 | 303.8 | 288.9 | 288.6 |
| Beneficio bruto | 359.9 | 365.6 | 335.1 | 299.5 | 306.4 |
| Gastos totales de explotación | 569.5 | 577.4 | 507.6 | 514.5 | 498.5 |
| Gastos de venta/general/administración Gastos, total | 162.7 | 167.1 | 144.8 | 152.2 | 146.1 |
| Investigación y desarrollo | 69 | 63.5 | 56.2 | 59.6 | 56.6 |
| Gastos (ingresos) extraordinarios | 10.8 | 5.7 | 1.6 | 13.6 | 6.9 |
| Other Operating Expenses, Total | 1.6 | -1.7 | 1.2 | 0.2 | 0.3 |
| Ingresos de explotación | 115.8 | 131 | 131.3 | 73.9 | 96.5 |
| Ingresos por intereses (gastos), netos No operativos | -9.1 | -10 | -2 | -4.3 | -2.5 |
| Ingresos netos antes de impuestos | 106.6 | 121 | 129.3 | 69.6 | 94 |
| Ingresos netos después de impuestos | 76.7 | 97.6 | 88.1 | 49.7 | 62.1 |
| Intereses menores | -0.9 | -0.9 | -0.3 | -0.2 | -0.5 |
| Beneficio neto antes de partidas extra. Elementos | 76.5 | 97.4 | 88.1 | 49.5 | 61.6 |
| Ingresos netos | 76.5 | 97.4 | 88.1 | 49.5 | 61.6 |
| Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | 76.5 | 97.4 | 88.1 | 49.5 | 61.6 |
| Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | 76.5 | 97.4 | 88.1 | 49.5 | 61.6 |
| Beneficio neto diluido | 76.5 | 97.4 | 88.1 | 49.5 | 61.6 |
| Promedio ponderado de acciones diluidas | 147.6 | 147.9 | 148.6 | 149.8 | 151.4 |
| BPA diluido sin partidas extraordinarias | 0.51829 | 0.65855 | 0.59287 | 0.33044 | 0.40687 |
| Dividends per Share - Common Stock Primary Issue | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| BPA normalizado diluido | 0.57094 | 0.68964 | 0.6002 | 0.39527 | 0.43698 |
| Equity In Affiliates | 0.7 | 0.7 | 0.3 | ||
| Otros, netos | -0.1 |
- Anual
- Trimestral
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total Activo Corriente | 2113.2 | 2471.8 | 1925 | 1796.3 | 1304.3 |
| Efectivo e inversiones a corto plazo | 645.5 | 1168.2 | 731.8 | 684.9 | 322.4 |
| Efectivo y Equivalentes | 645.5 | 1068.2 | 681.8 | 678.3 | 322.4 |
| Inversiones a corto plazo | 0 | 100 | 50 | 6.6 | 0 |
| Total deudores, neto | 472.7 | 416.9 | 335.3 | 362.2 | 357.2 |
| Accounts Receivable - Trade, Net | 472.7 | 416.9 | 335.3 | 362.2 | 357.2 |
| Total Inventory | 800.1 | 710.1 | 692.3 | 577.2 | 509.6 |
| Other Current Assets, Total | 194.9 | 176.6 | 165.6 | 172 | 115.1 |
| Total Assets | 3611.8 | 3650 | 3049 | 2771.5 | 2128.6 |
| Property/Plant/Equipment, Total - Net | 538.2 | 466 | 462.9 | 371.7 | 270.6 |
| Property/Plant/Equipment, Total - Gross | 984.9 | 901.1 | 895.4 | 797.3 | 692.4 |
| Accumulated Depreciation, Total | -446.7 | -435.1 | -432.5 | -425.6 | -421.8 |
| Goodwill, Net | 457.6 | 339.5 | 320.4 | 293 | 275.7 |
| Intangibles, Net | 270.9 | 211.8 | 229.1 | 233.2 | 218.7 |
| Other Long Term Assets, Total | 231.9 | 160.9 | 111.6 | 77.3 | 59.3 |
| Total Current Liabilities | 914.3 | 938.5 | 791.9 | 645.6 | 599.3 |
| Accounts Payable | 178.4 | 147.4 | 134.6 | 118.4 | 104.5 |
| Accrued Expenses | 195.1 | 186.1 | 181.4 | 164.4 | |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 18.7 | 112.4 | 2.2 | 0.5 | 18.5 |
| Other Current Liabilities, Total | 522.1 | 678.7 | 469 | 345.3 | 311.9 |
| Total Liabilities | 2498 | 2579.5 | 2087.8 | 1864.7 | 1232 |
| Total Long Term Debt | 1200.5 | 1221.8 | 842.3 | 812.8 | 322.6 |
| Long Term Debt | 1188.8 | 1219.2 | 839.7 | 811.7 | 322.6 |
| Deferred Income Tax | 62.3 | 46 | 43.1 | 48.8 | 51.1 |
| Minority Interest | 18 | 14.3 | 13.1 | 31.4 | 31.1 |
| Other Liabilities, Total | 302.9 | 358.9 | 397.4 | 326.1 | 227.9 |
| Total Equity | 1113.8 | 1070.5 | 961.2 | 906.8 | 896.6 |
| Common Stock | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 |
| Additional Paid-In Capital | 256.3 | 237.8 | 216.3 | 199.7 | 176.9 |
| Retained Earnings (Accumulated Deficit) | 1926 | 1659.5 | 1406.5 | 1274.7 | 1102.5 |
| Treasury Stock - Common | -1085 | -820.3 | -667 | -543.8 | -401.5 |
| Other Equity, Total | 14.8 | -8.2 | 3.7 | -25.5 | 17 |
| Total Liabilities & Shareholders’ Equity | 3611.8 | 3650 | 3049 | 2771.5 | 2128.6 |
| Total Common Shares Outstanding | 147.023 | 150.754 | 151.987 | 154.156 | 156.609 |
| Capital Lease Obligations | 11.7 | 2.6 | 2.6 | 1.1 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Total Activo Corriente | 2133 | 2113.2 | 2036.6 | 2087.5 | 2250.8 |
| Efectivo e inversiones a corto plazo | 597.9 | 645.5 | 626.2 | 723 | 916.1 |
| Efectivo y Equivalentes | 597.9 | 645.5 | 626.2 | 723 | 816.1 |
| Inversiones a corto plazo | 0 | 0 | 0 | 100 | |
| Total deudores, neto | 471.7 | 472.7 | 421.3 | 402.6 | 413.8 |
| Accounts Receivable - Trade, Net | 471.7 | 472.7 | 421.3 | 402.6 | 413.8 |
| Total Inventory | 858.8 | 800.1 | 749.5 | 759 | 739.9 |
| Other Current Assets, Total | 204.6 | 194.9 | 239.6 | 202.9 | 181 |
| Total Assets | 3763.9 | 3611.8 | 3336.9 | 3384.8 | 3550.7 |
| Property/Plant/Equipment, Total - Net | 510.9 | 538.2 | 421.5 | 395 | 403.8 |
| Goodwill, Net | 527.3 | 457.6 | 381.5 | 396.2 | 384.3 |
| Intangibles, Net | 298.5 | 270.9 | 214 | 233.5 | 227.5 |
| Other Long Term Assets, Total | 294.2 | 231.9 | 283.3 | 272.6 | 284.3 |
| Total Current Liabilities | 1048.5 | 914.3 | 864.6 | 818.4 | 880.5 |
| Accounts Payable | 196.2 | 178.4 | 157.7 | 154.9 | 161.2 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 120.1 | 18.7 | 17 | 14 | 11 |
| Other Current Liabilities, Total | 732.2 | 717.2 | 689.9 | 649.5 | 708.3 |
| Total Liabilities | 2583.6 | 2498 | 2399.9 | 2414.3 | 2533.7 |
| Total Long Term Debt | 1109 | 1200.5 | 1136.8 | 1171 | 1205.4 |
| Long Term Debt | 1109 | 1200.5 | 1136.8 | 1171 | 1205.4 |
| Minority Interest | 30.5 | 18 | 16.7 | 20.2 | 21.1 |
| Other Liabilities, Total | 395.6 | 302.9 | 381.8 | 404.7 | 426.7 |
| Total Equity | 1180.3 | 1113.8 | 937 | 970.5 | 1017 |
| Redeemable Preferred Stock | 0 | 0 | 0 | 0 | |
| Common Stock | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 |
| Treasury Stock - Common | -1107.2 | -1085 | -1058.6 | -986.2 | -925.9 |
| Other Equity, Total | 2285.8 | 14.8 | 1993.9 | 1955 | 1941.2 |
| Total Liabilities & Shareholders’ Equity | 3763.9 | 3611.8 | 3336.9 | 3384.8 | 3550.7 |
| Total Common Shares Outstanding | 146.761 | 147.023 | 147.367 | 148.324 | 149.292 |
| Deferred Income Tax | 62.3 | ||||
| Additional Paid-In Capital | 256.3 | ||||
| Retained Earnings (Accumulated Deficit) | 1926 |
- Anual
- Trimestral
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Ingresos netos/Línea de salida | 298.5 | 280.6 | 161.4 | 198 | 181 |
| Efectivo de actividades de explotación | 274.4 | 282.4 | 332.2 | 213.4 | 239.7 |
| Efectivo de actividades de explotación | 88.8 | 89.1 | 80.4 | 75.6 | 64.9 |
| Deferred Taxes | -14.8 | -5.8 | -22.5 | -5.4 | -15.1 |
| Partidas no monetarias | 46 | 44.1 | 43.3 | 19.7 | 51.1 |
| Cash Taxes Paid | 147.4 | 145.5 | 43 | 61.3 | 60.5 |
| Intereses pagados en efectivo | 24.3 | 19.6 | 28.7 | 16 | 11.7 |
| Cambios en el capital circulante | -144.1 | -125.6 | 69.6 | -74.5 | -42.2 |
| Efectivo de actividades de inversión | -251.6 | -192.4 | -192.7 | -158.4 | -123.4 |
| Gastos de capital | -129.2 | -92 | -97.2 | -73 | -49.2 |
| Otras partidas de flujo de caja de inversión, total | -122.4 | -100.4 | -95.5 | -85.4 | -74.2 |
| Efectivo procedente de actividades de financiación | -415.3 | 318.7 | -161.6 | 300 | -112.4 |
| Elementos de flujo de caja de financiación | -14.5 | -0.5 | -8.8 | -10.6 | -3.2 |
| Total Cash Dividends Paid | -29.8 | -24.2 | -24.6 | -25 | -25.1 |
| Emisión (retiro) de acciones, neto | -260.3 | -146.3 | -119.9 | -131.4 | 9.4 |
| Emisión (amortización) de deuda, neta | -110.7 | 489.7 | -8.3 | 467 | -93.5 |
| Efectos del cambio de divisas | -30.5 | -22.5 | 25.7 | 0.6 | -6.5 |
| Variación neta de la tesorería | -423 | 386.2 | 3.6 | 355.6 | -2.6 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 77.4 | 298.5 | 200.2 | 111.8 | 62.1 |
| Cash From Operating Activities | 87.5 | 274.4 | 102.9 | 33.4 | 77.8 |
| Cash From Operating Activities | 25.1 | 88.8 | 64.3 | 43.3 | 21.7 |
| Deferred Taxes | 1.2 | -14.8 | -25.7 | -8.2 | -4 |
| Non-Cash Items | 8.6 | 46 | 34.8 | 21.6 | 1.8 |
| Changes in Working Capital | -24.8 | -144.1 | -170.7 | -135.1 | -3.8 |
| Cash From Investing Activities | -108.2 | -251.6 | -102.3 | -44.7 | -101.8 |
| Capital Expenditures | -25 | -129.2 | -94.6 | -36.9 | -19 |
| Other Investing Cash Flow Items, Total | -83.2 | -122.4 | -7.7 | -7.8 | -82.8 |
| Cash From Financing Activities | -30.7 | -415.3 | -379.2 | -297.2 | -217.4 |
| Financing Cash Flow Items | 4.3 | -14.5 | -12.3 | -12.2 | -1.2 |
| Total Cash Dividends Paid | -7.4 | -29.8 | -22.4 | -15 | -7.5 |
| Issuance (Retirement) of Stock, Net | -21.7 | -260.3 | -236 | -162.6 | -102.5 |
| Issuance (Retirement) of Debt, Net | -5.9 | -110.7 | -108.5 | -107.4 | -106.2 |
| Foreign Exchange Effects | 4.1 | -30.5 | -63.8 | -36.9 | -10.7 |
| Net Change in Cash | -47.3 | -423 | -442.4 | -345.4 | -252.1 |
| Nombre del Inversor | Tipo de inversor | Porcentaje pendiente | Acciones en propiedad | Cambio de acciones | Fechas de holding | Índice de rotación |
|---|---|---|---|---|---|---|
| Laukien (Frank H) | Individual Investor | 26.982 | 39589954 | -600000 | 2023-05-16 | LOW |
| T. Rowe Price Investment Management, Inc. | Investment Advisor | 10.0131 | 14691904 | -1676240 | 2023-03-31 | MED |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 7.574 | 11113147 | 89092 | 2023-03-31 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 6.6837 | 9806862 | -160344 | 2023-03-31 | LOW |
| Fidelity Management & Research Company LLC | Investment Advisor | 6.3064 | 9253273 | -393849 | 2023-03-31 | LOW |
| Laukien (Joerg C) | Individual Investor | 5.1223 | 7515769 | 0 | 2022-12-31 | |
| MFS Investment Management | Investment Advisor/Hedge Fund | 4.996 | 7330498 | 61034 | 2023-03-31 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 2.2552 | 3308939 | 71574 | 2023-03-31 | LOW |
| AllianceBernstein L.P. | Investment Advisor/Hedge Fund | 1.87 | 2743740 | -353226 | 2023-03-31 | LOW |
| T. Rowe Price Associates, Inc. | Investment Advisor | 1.7501 | 2567833 | -382242 | 2023-03-31 | LOW |
| Fuller & Thaler Asset Management Inc. | Investment Advisor/Hedge Fund | 1.536 | 2253694 | 86411 | 2023-03-31 | LOW |
| Pallas Capital Advisors LLC | Investment Advisor | 1.1831 | 1735945 | 0 | 2023-03-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.1467 | 1682457 | -8588 | 2023-03-31 | LOW |
| Fidelity Institutional Asset Management | Investment Advisor | 1.0989 | 1612331 | -73588 | 2023-03-31 | LOW |
| Brown Advisory | Investment Advisor/Hedge Fund | 1.0819 | 1587450 | 26251 | 2023-03-31 | LOW |
| TD Asset Management Inc. | Investment Advisor | 0.9476 | 1390353 | -170892 | 2023-03-31 | LOW |
| Citadel Advisors LLC | Hedge Fund | 0.9379 | 1376143 | 978996 | 2023-03-31 | HIGH |
| Alyeska Investment Group, L.P. | Hedge Fund | 0.8949 | 1313065 | 568267 | 2023-03-31 | |
| Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.837 | 1228130 | 27256 | 2023-03-31 | LOW |
| RTW Investments L.P. | Investment Advisor/Hedge Fund | 0.8092 | 1187342 | 1187342 | 2023-03-31 | LOW |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com Group535K+
Traders
87K+
Clientes activos mensualmente
$113M+
Volumen mensual de inversión
$64M+
Retiros por mes
Calculadora de trading
Calcula tus P&L hipotéticas en el supuesto de haber abierto una operación con CFD en una fecha determinada (selecciona una fecha) y haberla cerrado en otra fecha (selecciona una fecha).
Comisión de la operación
0
- 1:1
Apalancamiento
1:1
- 20
- 100
- 500
- 1000
- 10000
Inversión
Tamaño de la operación (Apalancamiento x Inversión)
Apertura
Cierre
En corto En largo
Bruker Company profile
Sobre Bruker Corporation
Bruker Corporation diseña y fabrica instrumentos científicos y soluciones analíticos y diagnósticos. Sus segmentos incluye el Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & el Segmento Supercon Technologies (BEST). El segmento de Bruker BioSpin Group diseña, fabrica y distribuye herramientas de ciencias biológicas. El segmento Bruker CALID diseña, fabrica y distribuye instrumentos de espectrometría de masa de ciencias biológicas que se pueden integrar y utilizar junto con otros instrumentos de preparación de muestras o cromatografía, así como productos de detección químicos. El segmento de Bruker Nano diseña, fabrica y distribuye instrumentos de espectrometría y microscopia. El segmento BEST desarrolla y fabrica materiales y dispositivos superconductores y no superconductores. También se centra en instrumentos de prueba nanomecánicos.
El precio actual de la acción Bruker en tiempo real es 62.98 USD. El gráfico de la acción permite a los inversores comprender mejor el rendimiento y el precio de la acción y tomar decisiones informadas al negociar acciones y CFD.
Descubra más acciones con gráficos, datos vitales y actualizaciones de precios en tiempo real: Tivity Health, Gen Digital Inc., Lippo Malls Tr, PDF Solutions, Air France-Klm y Direxion Daily Junior Gold Miners Index Bear 2X Shares. Para obtener más información, consulte los perfiles de las empresas en Capital.com.
| Industry: | Advanced Medical Equipment & Technology (NEC) |
40 Manning Rd
BILLERICA
MASSACHUSETTS 01821-3915
US
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 535.000 traders de todo el mundo que eligen operar con Capital.com